that the MICs of cefoxitin and cefuroxime reduced, but again not to a value as low as against
FQ3. This confirmed the result of the gene inactivation experiment that kvrA loss alone is not Given that inactivation of either kvrA or nlpD in FQ3 reduced cephalosporin susceptibility, we 1 1 4 performed LC-MS/MS envelope proteomics for these mutants versus FQ3 as above, which 1 1 5
revealed that mutation in kvrA caused a reduction in OmpF (OmpK35) and OmpC (OmpK36) 1 1 6 porin levels in FQ3, to the same extent as seen in FQ3 M1. Mutation in nlpD, despite altering 1 1 7 cephalosporin MIC, did not ( Fig. 1 A, B) . Because FQ3 is derived from Ecl8, a laboratory 1 1 8 strain, and because FQ3 carries mutations that increase efflux pump production (9), we 1 1 9
wanted to test the impact of kvrA inactivation in a wild-type clinical isolate. To do this, we 1 2 0 insertionally inactivated kvrA (as above) in the susceptible K. pneumoniae clinical isolate 1 2 1 S17, which has wild-type envelope permeability (26) and showed by LC-MS/MS that OmpF 1 2 2
and OmpC levels fell in this mutant relative to S17, as seen in FQ3. Porin abundance did not 1 2 3 change upon nlpD inactivation in S17, also as seen in FQ3 ( Fig. 1 C, D) . occur by loss of function mutation in ompK36, which encodes is the primary porin for 1 3 6 meropenem entry (32, 33) . We therefore wanted to test the impact of OmpK36 porin 1 3 7 reduction seen following inactivation of kvrA in K. pneumoniae S17 (Fig. 1C) we used pUBYT::bla KPC-3 (25) to transform K. pneumoniae S17, S17ΔkvrA and 1 4 0 S17ΔompK36 (as a control). As expected, due to carriage of KPC, all transformants were doublings higher than against S17) and 32 µg.mL -1 respectively ( In conclusion, we report here two loss of function mutations in genes previously not known to 1 4 9 affect antimicrobial susceptibility in K. pneumoniae. NlpD ("new lipoprotein D") is conserved
across Gram-negative bacteria, with essential roles in virulence, e.g. in Yersinia pestis (34). targeted to the division site (35, 36) . This provides a clear rationale for why disruption of nlpD We also report that inactivation of kvrA causes cefuroxime resistance in K. pneumoniae, but reduce OmpC/OmpF production and can also affect antimicrobial susceptibility (37). KvrA is a MarR-family transcriptional repressor. Importantly, we found that YdhJ is 1 6 5 upregulated 45-fold (p=0.002, n=3) and >100-fold (p<0.0001, n=3) according to proteomics 1 6 6
following disruption of kvrA in K. pneumoniae S17 and FQ3, respectively. YdhJ is encoded pneumoniae. Therefore, the ydhIJK operon is likely to be the direct repressive target of KvrA that kvrA mutants are present in human clinical samples. We declare no conflicts of interest. to OmpA protein ratio in FQ3 and its mutant derivatives. (C) OmpC to OmpA protein ratio 2 1 1 and (D) OmpF to OmpA protein ratio in clinical isolate S17 and its mutant derivatives. Values reported are the means of three repetitions rounded to the nearest integer for the 2 1 8
diameter of the growth inhibition zone across each antimicrobial disc (mm). Shading indicates resistance according to susceptibility breakpoints set by the CLSI (11). Strains were grown in nutrient broth and raw abundance data are provided for three biological replicates of parent (FQ3) and mutant (FQ3 M1). Analysis was as described in (9) and proteins listed are those with significantly different abundance in FQ3 M1 versus FQ3. The CLSI susceptible and resistance breakpoints (11) for cefuroxime and cefoxitin are ≤ 8 2 2 7 and ≥ 32 µg.mL -1 . The CLSI susceptible and resistance breakpoints (11) 
